TY  - JOUR
AU  - Diaz de la Guardia, Rafael
AU  - Velasco-Hernandez, Talia
AU  - Gutierrez-Aguera, Francisco
AU  - Roca-Ho, Heleia
AU  - Molina, Oscar
AU  - Nombela-Arrieta, Cesar
AU  - Bataller, Alex
AU  - Luis Fuster, Jose
AU  - Anguita, Eduardo
AU  - Vives, Susana
AU  - Zamora, Lurdes
AU  - Nomdedeu, Josep
AU  - Teresa Gomez-Casares, Maria
AU  - Ramirez-Orellana, Manuel
AU  - Lapillonne, Helene
AU  - Ramos-Mejia, Veronica
AU  - Carlos Rodriguez-Manzaneque, Juan
AU  - Bueno, Clara
AU  - Lopez-Millan, Belen
AU  - Menendez, Pablo
PY  - 2021
DO  - 10.1182/bloodadvances.2020003958
SN  - 2473-9529
UR  - https://hdl.handle.net/10668/28398
T2  - Blood advances
AB  - Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Disease heterogeneity is well documented, and patient stratification determines treatment decisions. Patient-derived xenografts (PDXs) from risk-stratified AML are crucial for...
LA  - en
PB  - Elsevier
KW  - AML biology and
KW  - testing novel
KW  - We characterize
KW  - human AML
KW  - Acute myeloid-leukemia
KW  - Mesenchymal stem-cells
KW  - Initiating cells
KW  - Xenotransplantation model
KW  - Myelodysplastic syndrome
KW  - Progenitor cells
KW  - Niche
KW  - Nucleophosmin
KW  - Frequency
TI  - Engraftment characterization of risk-stratified AML in NSGS mice
TY  - research article
VL  - 5
ER  -